-
Mashup Score: 1Critical illness in patients with hematologic malignancy: a population-based cohort study - PubMed - 3 year(s) ago
Critical illness in patients with a newly diagnosed hematologic malignancy is frequent, occurring early after diagnosis. Certain baseline characteristics can help identify those patients at the highest risk.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Biliary cancers are difficult to diagnose, but a new test shows promise as a diagnostic tool.
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In patients with suspicious biliary strictures, a new next-generation sequencing assay called Bilemut improved #malignancy detection and reduced treatment delays, compared with an initial pathological diagnosis. https://t.co/WA1aTnsM2y https://t.co/NJePxnOhxZ
-
-
Mashup Score: 5Monocyte Regulation in Homeostasis and Malignancy - 3 year(s) ago
Monocytes are progenitors to macrophages and a subclass of dendritic cells (monocyte-derived dendritic cells, MoDCs), but they also act as circulating sensors that respond to environmental changes and disease. Technological advances have defined the production of classical monocytes in the bone marrow through the identification of lineage-determining transcription factors (LDTFs) and have…
Source: Trends in ImmunologyCategories: Allergy-Immunology, Latest HeadlinesTweet-
Read the Feature Review @TrendsImmuno on #Monocyte Regulation in #Homeostasis & #Malignancy by Jeffrey Pollard, Christopher Glass & colleagues #AACR21 https://t.co/0cr9RbcxTh https://t.co/a8Q4jYZZHX
-
-
Mashup Score: 1Machine learning can predict malignancy risk in patients with multiple pulmonary nodules - 3 year(s) ago
A newly developed machine learning-based model successfully predicted risk for malignancy in patients with multiple pulmonary nodules, researchers reported in Clinical Cancer Research.“The increasing detection rate of multiple pulmonary nodules has led to an emerging problem for lung cancer diagnosis,” Young Tae Kim, MD, PhD, professor in the department of thoracic and cardiovascular
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
A newly developed #machine learning-based tool demonstrated success in predicting #malignancy among patients with multiple #PulmonaryNodules, according to results published in @CCR_AACR @HemOncToday https://t.co/AEjk86x13d
-
-
Mashup Score: 1Machine learning can predict malignancy risk in patients with multiple pulmonary nodules - 3 year(s) ago
A newly developed machine learning-based model successfully predicted risk for malignancy in patients with multiple pulmonary nodules, researchers reported in Clinical Cancer Research.“The increasing detection rate of multiple pulmonary nodules has led to an emerging problem for lung cancer diagnosis,” Young Tae Kim, MD, PhD, professor in the department of thoracic and cardiovascular
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
A newly developed #machine learning-based tool demonstrated success in predicting #malignancy among patients with multiple #PulmonaryNodules, according to results published in @CCR_AACR @HemOncToday https://t.co/AEjk86x13d
-
-
Mashup Score: 0Machine learning can predict malignancy risk in patients with multiple pulmonary nodules - 3 year(s) ago
A newly developed machine learning-based model successfully predicted risk for malignancy in patients with multiple pulmonary nodules, researchers reported in Clinical Cancer Research.“The increasing detection rate of multiple pulmonary nodules has led to an emerging problem for lung cancer diagnosis,” Young Tae Kim, MD, PhD, professor in the department of thoracic and cardiovascular
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
A newly developed #machine learning-based tool demonstrated success in predicting #malignancy among patients with multiple #PulmonaryNodules, according to results published in @CCR_AACR @HemOncToday https://t.co/Kl4LFpi1vr
-
A newly developed #machine learning-based tool demonstrated success in predicting #malignancy among patients with multiple #PulmonaryNodules, according to results published in @CCR_AACR @HemOncToday https://t.co/lse8kTi9iI
-
-
Mashup Score: 4
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Treatment of Cancer‐Associated Venous Thromboembolism with Low‐Molecular‐Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats #Thrombosis #VenousThromboembolism #Cancer #Malignancy #Treatment https://t.co/R9Dky5qeLD https://t.co/hjkEVIFU7f
-
-
Mashup Score: 2Issue: Trends in Immunology - 3 year(s) ago
The Immunologists’ Guide to Pandemic PreparednessImmunologists are central to fighting any pandemic. From pathogenesis to disease modeling, pharmaceuticals to vaccines, immunologists play a crucial role in translating basic science into effective response strategies. This article describes our view on how lessons from the coronavirus disease 2019 (COVID-19) pandemic can be developed into an…
Source: www.cell.comCategories: Allergy-Immunology, Latest HeadlinesTweet-
Read the February issue @TrendsImmuno: #COVID19 & #complement & #vaccines, #monocytes in #homeostasis & #malignancy, #gland #macrophages, #immunoregulation & #gut #commensal #translocation, early #type2immunity, #Tcelldevelopment & #scRNAseq, & more!! https://t.co/pcaytlddXK https://t.co/tVlWcWHQHz
-
-
Mashup Score: 0Close to the Bone: SKCC Investigators Uncover Link between Mitochondrial Metabolism and Chondrosarcoma | Sidney Kimmel Cancer Center - 4 year(s) ago
Cancer Care 360 at the Sidney Kimmel Cancer Center in Philadelphia is a comprehensive circle of care – research, treatment and support – with you in the center.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New SKCC research sheds light on a key cellular change that contributes to the #malignancy of a common form of #bonecancer, #chondrosarcoma, which might aid in the development of biomarkers & therapeutic approaches: https://t.co/samTlMw1wj @ResearchAtJeff #ResearchWednesday https://t.co/DnxzjXuEW2
-
-
Mashup Score: 2
TMPRSS2 is an important membrane-anchored serine protease involved in human prostate cancer progression and metastasis. A serine protease physiologically often comes together with a cognate inhibitor for execution of proteolytically biologic function; however, TMPRSS2’s cognate inhibitor is still elusive. To identify the cognate inhibitor of TMPRSS2, in this study, we applied…
Source: OncogeneCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Study by @LeeShyue indicate that HAI-2 can function as a #inhibitor for TMPRSS2 in human #prostate cancer cells and may serve as a potential factor to suppress TMPRSS2-mediated #malignancy. Read about in @oncogenejournal https://t.co/PjOJJ6TfQh
-
#Critical #illness in patients with #hematologic #malignancy: a population-based cohort study #ICU https://t.co/WEMU96fjzj https://t.co/ztrqdZJMwb